Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Thermo Fisher Scientific (NY: TMO )

524.05 +7.36 (+1.42%)
Official Closing Price Updated: 7:00 PM EST, Dec 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,758,855
Open 516.69
Bid (Size) 524.05 (1)
Ask (Size) 528.86 (1)
Prev. Close 516.69
Today's Range 515.00 - 526.43
52wk Range 493.30 - 627.88
Shares Outstanding 393,418,899
Dividend Yield 0.30%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Quest Diagnostics (NYSE: DGX) And Mainz Biomed (NASDAQ: MYNZ) Team Up To Commercialize ColoAlert Early Cancer Detection Screening In The U.S.
Quest Diagnostics (NYSE: DGX) And Mainz Biomed (NASDAQ: MYNZ) Team Up To Commercialize ColoAlert Early Cancer Detection Screening In The U.S. 
Via News Direct
Exposures Product Safety
Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 10 Years
Via Benzinga

Performance

YTD
-3.69%
-3.69%
1 Month
+1.54%
+1.54%
3 Month
-14.14%
-14.14%
6 Month
-7.40%
-7.40%
1 Year
-0.95%
-0.95%

More News

Read More
Thermo Fisher Scientific Completes $1B Share Repurchase
From Thermo Fisher Scientific Inc.
Via Business Wire
Mainz Biomed Announces Reverse Stock Split Soon After Collaborating With MedTech Giant Thermo Fisher Scientific
Via Benzinga
How Is The Market Feeling About Thermo Fisher Scientific?
Via Benzinga
Check Out What Whales Are Doing With TMO
Via Benzinga
Market Whales and Their Recent Bets on TMO Options
Via Benzinga
Earnings Outlook For Thermo Fisher Scientific
Via Benzinga
Mainz Biomed Inks Major Deal To Develop A Next-Generation Cancer Test
Via News Direct
Thermo Fisher Scientific Authorizes $4 Billion of Share Repurchases
From Thermo Fisher Scientific Inc.
Via Business Wire
The Oncology Bet Is Already Paying Off For Pfizer
Via Benzinga
Exposures COVID-19
Healthcare Giant Thermo Fisher Scientific Inc. (NYSE: TMO) Inks Deal With Mainz Biomed (NASDAQ: MYNZ) To Develop And Commercialize Next Gen Colorectal Cancer Screening
Via News Direct
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,100 Today
Via Benzinga
(TMO) - Analyzing Thermo Fisher Scientific's Short Interest
Via Benzinga
Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets
From Mainz BioMed NV
Via GlobeNewswire
Thermo Fisher Scientific to Present at the Wolfe 2024 Healthcare Conference on November 19, 2024
From Thermo Fisher Scientific Inc.
Via Business Wire
Thermo Fisher Scientific Declares Quarterly Dividend
From Thermo Fisher Scientific Inc.
Via Business Wire
Here's How Much $100 Invested In Thermo Fisher Scientific 15 Years Ago Would Be Worth Today
Via Benzinga
Tradepulse Power Inflow Alert: Thermo Fisher Scientific Inc. Climbs Over 9 Points On Session After Alert
Via Benzinga
Wall Street Slumps For Third Straight Day As Investor Sentiment Fades, Dollar Strength Resumes, Boeing Disappoints: What's Driving Markets Wednesday?
Via Benzinga
Thermo Fisher Scientific (TMO) Q3 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Thermo Fisher Scientific Sails Through Q3 With Mixed Earnings, CEO Says In Great Position To Deliver 2024 Objectives
Via Benzinga
Thermo Fisher Scientific Reports Third Quarter 2024 Results
From Thermo Fisher Scientific Inc.
Via Business Wire
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Via Benzinga
Novo Nordisk/AstraZeneca's Manufacturing Partner Thermo Fisher Questioned Over Manufacturing Lapses
Via Benzinga
Exposures Product Safety
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.